Jae B. Kim - Net Worth and Insider Trading

Jae B. Kim Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jae B. Kim owns 1 companies in total, including Avidity Biosciences Inc (RNA) .

Click here to see the complete history of Jae B. Kim’s form 4 insider trades.

Insider Ownership Summary of Jae B. Kim

Ticker	Comapny	Transaction Date	Type of Owner
RNA	Avidity Biosciences Inc	2020-07-27	Chief Medical Officer

Jae B. Kim Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jae B. Kim Ownership Network

Ownership Network List of Jae B. Kim

No Data

Ownership Network Relation of Jae B. Kim

Jae B. Kim Owned Company Details

What does Avidity Biosciences Inc do?

Who are the key executives at Avidity Biosciences Inc?

Jae B. Kim is the Chief Medical Officer of Avidity Biosciences Inc. Other key executives at Avidity Biosciences Inc include Chief Human Resources Officer Teresa Mccarthy , Chief Technical Officer W. Michael Flanagan , and Chief Scientific Officer Arthur A Levin .

Avidity Biosciences Inc (RNA) Insider Trades Summary

Over the past 18 months, Jae B. Kim made no insider transaction in Avidity Biosciences Inc (RNA). Other recent insider transactions involving Avidity Biosciences Inc (RNA) include a net sale of 179,500 shares made by Arthur A Levin , a net sale of 589,166 shares made by Sarah Boyce , and a net sale of 232,089 shares made by Michael F Maclean .

In summary, during the past 3 months, insiders sold 202,394 shares of Avidity Biosciences Inc (RNA) in total and bought 0 shares, with a net sale of 202,394 shares. During the past 18 months, 1,163,313 shares of Avidity Biosciences Inc (RNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,163,313 shares.

Avidity Biosciences Inc (RNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avidity Biosciences Inc Insider Transactions

No Available Data

Jae B. Kim Mailing Address

Above is the net worth, insider trading, and ownership report for Jae B. Kim. You might contact Jae B. Kim via mailing address: C/o Avidity Biosciences, Inc., 10975 N. Torrey Pines Rd., Suite 150, La Jolla Ca 92037.

Discussions on Jae B. Kim

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.